MAPT and Alzheimer disease: Taken together, ginsenosides Rb1, Rg2, Re, and Rd can regulate apoptosis-related proteins, including Bcl-2, Bax, and Cyto C, reducing Aβ-induced or tau protein–induced neurotoxicity during AD development.